SCHEMBL26181835

SCHEMBL26181835

C#CCOCCOCCOCCOCCC(=O)N1C[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@H](CO)C(=O)N[C@H]2CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CCN)NC2=O)[C@@H](C)O)C(C)C)[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@H](CO)C(=O)N[C@H]2CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CCN)NC2=O)[C@@H](C)O)C(C)C)C1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.65
RCOR1 Q9UKL0 2/20 0.65
TEAD4 Q15561 1/20 0.38
TEAD3 Q99594 1/20 0.38
F11 P03951 1/20 0.38
TERF2IP Q9NYB0 2/20 0.38
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
NPY4R P50391 1/20 0.37
NPY5R Q15761 1/20 0.37
SSTR2 P30874 3/20 0.36
SSTR4 P31391 2/20 0.36
SSTR5 P35346 2/20 0.36
MDM2 Q00987 1/20 0.36
PRKAR2A P13861 7/20 0.36
PRKAR2B P31323 5/20 0.36
TSLP Q969D9 1/20 0.35
SSTR1 P30872 1/20 0.35
SSTR3 P32745 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26181836 0.98 KDM1A (0.68) KDM1ARCOR1TEAD4TEAD3F11
SCHEMBL26181847 0.97 KDM1A (0.67) KDM1ARCOR1F11TERF2IPSSTR2
SCHEMBL25582800 0.96 KDM1A (0.64) KDM1ARCOR1F11TERF2IPNPY1R
SCHEMBL25582813 0.96 KDM1A (0.65) KDM1ARCOR1TEAD4TEAD3F11
SCHEMBL25582804 0.94 KDM1A (0.66) KDM1ARCOR1TEAD4TEAD3F11
SCHEMBL25582809 0.94 KDM1A (0.67) KDM1ARCOR1TEAD4TEAD3F11
SCHEMBL25582811 0.91 KDM1A (0.61) KDM1ARCOR1TEAD4TEAD3TERF2IP
SCHEMBL25582795 0.90 KDM1A (0.62) KDM1ARCOR1TERF2IPNPY1RNPY2R
SCHEMBL25582796 0.88 KDM1A (0.58) KDM1ARCOR1TERF2IPNPY1RNPY2R
SCHEMBL26181706 0.85 KDM1A (0.78) KDM1ARCOR1TERF2IPSSTR2SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190950-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS CIDARA THERAPEUTICS, INC. 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190950-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS FCGR3B, FCGR1A, FCGR2A KDM1A 4789/4885RCOR1 4863/4885TEAD4 4759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.